Why the study?
Arrhythmic complications have been described during the COVID-19 pandemic, but specific considerations regarding SARS-CoV-2 and its various arrhythmic manifestations need to be highlighted.
This review highlights specific considerations for managing atrial, ventricular, and bradyarrhythmias in patients with COVID-19.
Answers are grounded in this paper and cite their sources.
Arrhythmia management in COVID-19 requires tailored vigilance; leaves open the need for prospective trials to define standards.
Coronavirus disease 2019 (COVID-19) has encompassed the globe since it was first observed just under 2 years ago. Although the disease is predominantly a respiratory illness, there have been observed complications throughout the various organ systems. Namely, cardiovascular complications, and, more specifically, arrhythmic complications have been described throughout the pandemic in patients with COVID-19. Management of atrial arrhythmias, ventricular arrhythmias, and bradyarrhythmias in patients with COVID-19 infection has been largely guided by our prior experience in the management of these arrhythmias in similar patient populations without infection. However, this review aims to highlight the specific considerations as they pertain to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the various arrhythmic manifestations observed with this disease.
No takes yet. Share an insight, caveat, or question.
Lavelle et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: